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ABSTRACT 
Objective: The study evaluates the acute toxicity of the Swietenia Mahagoni leaf in rats of Wistar strain.  
Methods: Whole leaf powder at a maximum allowable dose (as per OECD guidelines (2000 mg Kg-1
Keywords: Swietenia mahagoni, Acute toxicity, Hepatic enzymes, Histopathology. 
 BW)) was orally administered for 14 d and the 
effect of administration on the mortality, behavioral and biochemical changes in rats was observed.  
Results: There was no mortality or any toxic reaction was recorded in the treated group in the duration of administration. The powder did not 
cause any behavioral or physical changes in experimental rats. There was no significant (p ≤ 0.05) difference in the serum biochemical parameters 
analyzed between the normal control and test groups. Hematological parameters in the test group were also similar to the normal control group.  
Conclusion: The study establishes the non-toxicity of the Swietenia mahagoni leaf powder in therapeutic uses. 
 
INTRODUCTION 
Traditional medicine is the most widely used treatment for a long 
time to treat various human ailments in many parts of the world. 
WHO reports that about 80% of the people living in the developing 
countries depend on traditional plant-based medicine for basic 
health care needs [1]. Medicinal plants are blessed with a wide array 
of phytochemicals with various physiological actions; most of them 
are beneficial to human health and well being [2]. But some of the 
bio-actives derived from plants may have physiological actions that 
are deleterious to human health [3]. To develop a medicinal plant or 
its derivative(s) as a pharmaceutical, require the results from animal 
tests that are used in combination with results on the 
pharmacological efficacy of a medicinal plant, to decide whether the 
beneficial effects of the treatment would outweigh the risks of 
adverse side effects, and to establish a safe dose for use in clinical 
trials. The toxicological studies also evaluate the potential side 
effects that must be monitored carefully while using as 
pharmaceutical.  
Swietenia mahagoni Jacq. Is a small leafy, medium sized tree native 
to the west indies. Around the world, the plant is commonly called as 
West Indies mahogany, caoba, caoba dominicana or acajou. It is one 
of the species of genus Swietenia which belongs to chinaberry 
family, meliacea [4-6]. The parts of the plant have been used to treat 
many human ailments such as malaria, diabetes, diarrhea, 
astringent, hypertension etc. locally. The fruit of the plant is used as 
the powerful anti-hyperglycemic drug. The seed oil is being used as 
an alternative body ointment therapy for a range of skin cuts, itches 
and wounds to ameliorate the healing process in African countries. 
Decoction of bark is used to increase appetite, as an energizer in case 
of tuberculosis, to treat anemia, diarrhea, dysentery, fever and 
toothache. The decoction of leaves is used to treat nerve disorders, 
the infusion of seed to relief from chest pain [7, 8]. There are no data 
regarding the toxic effects, dose and long term side effects of 
treatment in the animal system. The present study evaluates the 
effect of an acute dose of the leaf powder on normal physiology, 
biochemistry and behavior in rats. 
MATERIALS AND METHODS 
Chemicals and reagents 
Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), 
Alkaline phosphatase (ALP), Total protein, albumin, urea, creatinine, 
total bilirubin, tryglycerides, total cholesterol assay kits were 
purchased from Aggappe Diagnostics, Ernakulam, India. Reduced 
glutathione (GSH), 5, 5-dithio (bis) Nitro benzoic acid (DTNB) were 
purchased from Sigma-Aldrich, Bangalore, India. All the chemicals 
and reagents used in the study were of analytical grade. 
Collection and preparation of samples 
The leaf of Swietenia mahogani was collected from Mysore district of 
Karnataka, India and subsequently identified by Dr. G. R. 
Shivamurthy, Department of Studies in Botany, University of Mysore, 
Mysore, India. The collected sample was thoroughly washed under 
running water to remove adhering dirt and other foreign particles, 
dried overnight at 50 °C, powdered, passed through 60 mesh sieve 
and stored in air tight container at 4 °C till further use.  
Experimental animals 
Adult rats of Wistar strain weighing around 140-180 g were 
procured from the animal house of University of Mysore, Mysore. 
The obtained rats were kept in the polyacrylic cages in the room 
maintained by 25±2 °C, 45 to 60 % RH and 12 h photoperiod, and 
acclimatized for these standard conditions for 14 d. During the 
acclimatization period the animals were observed for general 
conditions every day. Pellet diet (procured from Amrut feeds, Pune, 
India) and water ad libitum were provided. The experimental 
protocols of toxicological study were reviewed and approved by the 
Institutional Animal Ethical Committee for the purpose of control 
and supervision of experiments on animals (UOM/IAEC/03/2013).  
Acute toxicity studies 
The animals were grouped into 2 groups Group I–Control; Group II–
Mahagony leaf powder consisting of 6 animals each (3 male, 3 
female) using Randomized Block design. According to OECD 
guidelines the Group-II was administered with leaf powder at a dose 
of 2000 mg kg-1body weight [9]. The powder was given in the form 
of suspensions for 14 d. The animals were observed individually 
after the initiation of dose during the first 30 min and at every half 
an hour interval of 6 h and thereafter and once in 24 h for 14 d. 
Individual records for physical or behavioral changes such as skin 
and fur, eyes and mucous membrane, respiratory, circulatory, 
autonomic and central nervous systems (ANS & CNS respectively) 
and somato motor activity, behavior pattern and mortality. 
Observations were also made for the presence of tremors, 
convulsions, salivation, diarrhea, lethargy, sleep and coma. At the 
end of the study period, animals were euthanized and decapitated. 
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Biochemical estimations 
Blood was collected by cardiac puncture, one part of the collected 
blood was taken in EDTA coated tubes and analyzed for 
hematological parameters, in another part, blood was allowed to 
coagulate and the serum was separated by centrifuging at 2500 × g 
for 20 min. In the serum, activities of alanine amino transferase 
(ALT), aspartate aminotransferase (AST) and alkaline phosphatase 
(ALP) were determined along with an estimation of total protein, 
albumin, urea, creatinine, total bilirubin, total cholesterol, triglycerides 
(TGL) and glutathione (GSH) using respective standard kits.  
The hematological parameters were analyzed in the Automated 
Hematology Analyzer (Sysmex KX–21). The parameters analyzed were 
PCV (Packed cell volume), WBC (White blood cells), RBC (Red blood 
cells), MCH (mean corpuscular hemoglobin), MCHC (mean corpuscular 
hemoglobin concentration), Hb (hemoglobin) and PLT (platelets). The 
analyses were carried out based on standard methods.  
Histopathological procedures 
After decapitation, liver and kidney were immediately excised. 
Excised organs were washed with phosphate buffered saline and 
weighed. Small portions of liver and kidney were fixed in 
formalin, dehydrated in graduate ethanol (50–100%), cleared in 
xylene and embedded in paraffin. Paraffin embedded tissues 
were sectioned into 4–5 µm thin and stained with haemotoxylin 
and eosin and examined and images were taken under 
photomicroscope (400 X) [10]. 
Statistical analysis 
All the expressed values are the mean of triplicate values with±SD. 
The data were subjected to a one way ANOVA followed by Tukey’s 
multiple comparison test for the significant difference (p ≤ 0.05) 
using SPSS 11.5 software. 
RESULTS 
Table 1 presents the data on toxic symptoms, behaviors and other 
changes. The powder did not show any toxic symptom during the 
study period. There were no significant changes in behavior, ANS or 
CNS was observed in any of the animals. There were no significant (p 
≥0. 05) changes in weights of major organs in proportion to their 
body weights (fig. 1and table 2) when compared to the control 
group. 
  
Table 1: Acute oral toxicity record sheet for the control and extract treated animals (n = 6) 
Drug P. O Toxicity Time of death Additional observations Behavioral observations 
ANS/CNS 




































CON nil nil 0 x x x x x X X X X x X x x x x x x 
SWL nil nil 0 x x x x x X X X X x X x x x x x x 
Con–Control; SML–swietenia mahagoni leaf. Lacri; lacrimination; Sali; salivation, Diah; diarrhea, Resp; respiratory distress, Leth; lethargy, Con; 
convulsions, Ste; stereotypy, Tre; tremors, Cat; catalepsy, Geo; effect on positive geotropism, Ret; retropulsion, Stu; stupor, Exe; excitement, ×-
absence of symptom, √-presence of symptom (n=6). 
 
Table 2: Organ weights in proportion to body weight 
 Liver Kidney Spleen Brain Heart 
Control 0.03±0.005 0.0058±0.0004 0.0025±0.0008 0.0077±0.0009 0.0036±0.0004 
Test 0.031±0.004 0.0061±0.0005 0.0021±0.0007 0.0081±0.0008 0.0031±0.0004 
The table indicates the ratio of organ weight to body weight in both the groups. The test group was administered with 2000 mg kg-1
 
 Mahagoni leaf 
powder and normal control group was administered with the physiological saline. The values are the mean values for each group with standard 
deviation (n=6). 
 
Fig. 1: Body weight of rats 
 
The fig. shows the effect of mahagoni leaf powder on the change in 
body weight pattern when compared to the normal control group. 
The test group was administered with 2000 mg kg-1
 
 and the normal 
control group was administered with the physiological saline. The 
values are the mean body weight of six rats in each group with 
standard deviation (n=6). 
Biochemical estimations 
The serum activities of hepatic enzymes and levels of selected 
biochemical parameters in serum were represented in Table. 3 
and 4. There were no significant differences in the serum 
activities (p ≤ 0.05) of ALP, ALT and AST between experimental 
and control groups. There was no significant (p ≤ 0.05) 
difference observed in biochemical parameters between the test 
and the control group.  
 
Table 3: Serum activity of liver enzymes in U/l 
Control Test group 
ALT 18.9±1.6 20±0.5 
ASP 49±2.4 52±1.6 
ALP 70±3.8 75±4 
The table shows the values of serum activities of hepatic enzymes. 
The test group was administered with 2000 mg kg-1 and normal 
control group was administered with the physiological saline. The 
values are the mean values for each group with standard deviation 
(n=6).
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Table 4: Biochemical parameters 
 Control Test group 
Total protein (g/dL) 5.72±0.17 5.84±0.28 
Albumin (g/dL) 4.06±0.22 4.18±0.29 
Creatinine (mg/dL) 0.53±0.20 0.55±0.15 
TGl (mg/dL) 95.8±3.2 98±2.1 
Total cholesterol (mg/dL) 67.5±13.42 52.66±5.46 
Glutathione 0.48±0.1 0.31±0.14 
Blood urea nitrogen (mg/dL) 16.66±1.86 14.66±2.73 




normal control group was administered with the physiological saline. The values are the mean values for each group with standard deviation (n=6). 
The liver histological sections of the control and extract treated 
groups are represented in fig. 2. There were no detectable changes 
in cellular morphology of hepatocytes. The hepatic architecture was 
normal with well-defined central vein. No necrosis, steatosis, chronic 
inflammatory infiltration or degenerative changes were observed in 
any of the test group animals.  
Fig. 3. shows the histology of kidney section. There was no alteration 
from the normal histology of kidney was observed, indicating the 
safety of mahagoni leaf powder. 
 
 
(a)     (b) 
Fig. 2: Liver sections (10 X) of (a) Normal group, (b) Treated group. Photographs shown are taken at 10X resolution. Normal architecture 
of liver having central vein and surrounded hepatic cells can be observed in both the groups. There were no observable changes in MAE 
treated group when compared to normal control group 
 
 
(a)     (b) 
Fig. 3: Kidney sections (10 X) of (a) Normal group, (b) Treated group. Photographs shown are taken at 20X resolution. Normal 
architecture of kidney with glomeruli can be observed in both the groups. There were no observable changes in MAE treated group when 
compared to normal control group 
 
Table 5: Hematological parameter 
Parameter Control Test group 
WBC (x103 6.3±0.7 /µl) 6.2±0.3 
RBC (x105 7.05±0.14 /µl) 7.19±1.8 
HGB (g/dl) 13.9±0.5 14.1±2 
HCT (%) 43.7±1.4 46.2±1.3 
MCV (FL) 62.0  59.0  
MCH (Pg) 18.6±1.1 19.1±0.5 
MCHC (g/dl) 30.0±2 30.0±3 
PLT (x103 980 /µl) 918 
CPV-% (Cell pack volume) 47.17 46.49 
The values in the table depict the treatment of rats with mahagoni leaf powder on the hematological parameters. The test group was administered 
with 2000 mg kg-1 and normal control group was administered with the physiological saline. The values are the mean values for each group with 
standard deviation. 
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Hematological studies 
Hematological parameters of both experimental and control groups 
were presented in Table. 5. The results indicate the hematological 
similarity between the control and test group. 
DISCUSSION  
Medicinal/herbal plants and their preparations are being used for 
thousands of years in all types of traditional medicinal practices 
because of their ease of availability and cost [11]. They are rich 
sources of numerous bioactive components which can prevent, treat 
and also can help in the management of several diseases/disorders 
and till date only few plants have been explored for their potential 
pharmacological activities. Although their long usage history in 
treating the ailments, there is very less documentation in the 
scientific literature regarding the dose, adverse side effects, route 
and form of administration of the medicinal plants. The maximum 
allowable dose and adverse side effects can be evaluated by 
toxicological study using the animal models. The present study 
evaluates the safety of the Swietenia mahagoni in its maximum 
allowable dose prescribed by the OECD. There were no sudden 
reactions such as hypersensitivity and allergic reactions following 
the administration of leaf powder. In addition, there was no 
behavioral or physical change observed during the whole study 
period. An increase in the body weights also was comparable to 
normal group. The ratio of the organ weights in the treated group 
was also comparable to the normal group, indicating absence of 
edema or physiological changes of the organs in the treated group. 
PCV and hemoglobin concentration indicates the normal health and 
physiology of red blood cells. In the conditions of damage to RBC by 
any toxic reaction, there will be decrease in RBC number and MCV 
[12]. The results indicated that the mahagoni treatment was not 
toxic to circulating red blood cells and platelets. All the other blood 
cells were also found to be in normal range and condition. 
Internal organs are integral to the central metabolism of the body. If 
there are any adverse effects on the internal organs by the 
administered drug, the effect will be reflected through changes in 
morphology and body weight and histopathology. Therefore, the 
observations on the changes in histopathology and relative weights 
of organs can infer the toxicity of the administered drug in 
experimental animals. From the results, it is observed that the organ 
weights in the experimental group are similar to control group, 
suggesting that oral administration of mahagoni leaf powder had no 
effect on the normal growth. Since there was no reduction in body 
and relative organ weights of the treated animals, even at the 
maximum dose tested, it can be proposed that the mahagoni leaf is 
nontoxic to the organs analyzed. 
The liver is the metabolic hub of the body which works to maintain 
the metabolic integration of all other organs. It acts as a synthetic 
site and metabolic sink for various biochemical components. If the 
normal metabolic function of the liver is hampered due to hepatic 
damage, there will be an elevation in serum levels of many 
biochemical markers in which ALT, AST, ALP and bilirubin are 
important and can be easily estimated [13]. The hepatic enzyme 
activities and the biochemical parameters analyzed in the mahagoni 
treated group indicated that there was no elevation from normal 
values. The histological sections of the liver of mahagoni treated 
group also supported the normal integrity of the liver.  
CONCLUSION 
The biochemical, histological and behavioral analysis inferred the 
safety of the Sweitenia mahagoni leaf powder. Hence, it can be 
concluded that Sweitenia mahagoni leaf powder is non toxic, non-
allergic and the leaf in the whole powder form or as additive in the 
food as neutraceutical can be used to treat various ailments. 
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